EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Phase to phase: Navigating drug combinations with hypomethylating agents in higher-risk MDS trials for optimal outcomes

Almuth Maria Anni Merz, Marie Sébert, Jan Sonntag, Anne Sophie Kubasch, Uwe Platzbecker, Lionel Adès

Cancer Treatment Reviews · 2024

DOI: 10.1016/j.ctrv.2023.102673 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2024. Verfasst von Almuth Maria Anni Merz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Disease, University Hospital of Leipzig, Leipzig, Germany. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic Syndromes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 101 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteLeukemia, Myelomonocytic, ChronicMyelodysplastic SyndromesHumansAntimetabolites, AntineoplasticAzacitidineClinical Trials as Topic

Stichwörter der Autor:innen

AzacitidineClinical trialsHigh-riskHypomethylating agentsImetelstatLuspaterceptMDSMyelodysplastic neoplasms

Substanzen

Antimetabolites, AntineoplasticAzacitidine

Autor:innen und Institutionen

  • Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Disease, University Hospital of Leipzig, Leipzig, Germany.
  • Service Hématologie Séniors, Hôpital Saint-Louis (AP-HP), Paris Cité University and INSERM U944, Paris, France.
  • Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Disease, University Hospital of Leipzig, Leipzig, Germany. Electronic address: uwe.platzbecker@medizin.uni-leipzig.de.
  • Service Hématologie Séniors, Hôpital Saint-Louis (AP-HP), Paris Cité University and INSERM U944, Paris, France. Electronic address: lionel.ades@aphp.fr.

Zitieren

APA

Merz, A. M. A., Sébert, M., Sonntag, J., Kubasch, A. S., Platzbecker, U., & Adès, L. (2024). Phase to phase: Navigating drug combinations with hypomethylating agents in higher-risk MDS trials for optimal outcomes. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2023.102673

Vancouver

Merz AMA, Sébert M, Sonntag J, Kubasch AS, Platzbecker U, Adès L. Phase to phase: Navigating drug combinations with hypomethylating agents in higher-risk MDS trials for optimal outcomes. Cancer Treatment Reviews. 2024. doi:10.1016/j.ctrv.2023.102673

BibTeX
@article{Merz2024,
  author = {Merz, Almuth Maria Anni and Sébert, Marie and Sonntag, Jan and Kubasch, Anne Sophie and Platzbecker, Uwe and Adès, Lionel},
  title = {Phase to phase: Navigating drug combinations with hypomethylating agents in higher-risk MDS trials for optimal outcomes},
  journal = {Cancer Treatment Reviews},
  year = {2024},
  doi = {10.1016/j.ctrv.2023.102673}
}
Kostenlos starten →